0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Editorials |

Observational Studies of Treatment Effectiveness: Some Cautions

Andreas Laupacis, MD, MSc; and Muhammad Mamdani, PharmD, MA, MPH
[+] Article and Author Information

From Institute for Clinical Evaluative Sciences, Toronto, Ontario M4N 3M5, Canada.


Potential Financial Conflicts of Interest: None disclosed.

Corresponding Author: Andreas Laupacis, MD, MSc, FRCPC, Institute for Clinical Evaluative Sciences, 2075 Bayview Avenue–G106, Toronto, Ontario M4N 3M5, Canada; e-mail, alaupacis@ices.on.ca.

Current Author Addresses: Drs. Laupacis and Mamdani: Institute for Clinical Evaluative Sciences, 2075 Bayview Avenue–G106, Toronto, Ontario M4N 3M5, Canada.


Ann Intern Med. 2004;140(11):923-924. doi:10.7326/0003-4819-140-11-200406010-00014
Text Size: A A A

The last decade has seen an extraordinary proliferation of evidence that statins decrease mortality in patients who have, or are at risk for developing, cardiovascular disease (12). The benefits extend to high-risk patients with normal cholesterol levels (2) and have led some to suggest that all individuals older than 55 years of age should receive statins as part of a “polypill” (3). In this issue, Spencer and colleagues (4) add to the evidence in favor of statins. They conclude that statin users with an acute coronary syndrome are less likely to present with ST-segment elevation or myocardial infarction than those not receiving statins (odds ratio, 0.78 [95% CI, 0.70 to 0.86]). More surprisingly, they also conclude that starting statin therapy after admission markedly decreases in-hospital mortality (odds ratio, 0.38 [CI, 0.30 to 0.48]).

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)